New study tests best method to quit antidepressants without relapse
NCT ID NCT07393919
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two strategies for safely stopping antidepressants in adults whose depression is in remission. Participants will be randomly assigned to either a standard gradual dose reduction or a more precise hyperbolic tapering method. The goal is to see which approach leads to more successful discontinuation with fewer withdrawal symptoms or relapse over 36 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who returns to work after stress treatment?
- Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Can a Three-Session therapy rival CBT for Event-Related depression?
- Your genes could hold the key to better depression treatment
- A therapy that aims to boost wellbeing, not just ease symptoms — a trial puts it to the test